Lv1
30 积分 2022-06-02 加入
Abstract 1828: AZD8853: A novel antibody targeting GDF15 for immunotherapy refractory tumors
30天前
已关闭
Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells
1个月前
已完结
Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells
1个月前
已完结
Heterologous expression and functional analysis of rat NaV1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7–23
1个月前
已完结
PSGL-1 is a novel macrophage checkpoint in immuno-oncology
2个月前
已关闭
Abstract 5602: VTX-0811, a first-in-class PSGL-1 blocking monoclonal antibody, repolarizes tumor associated macrophages and induces inflammation in the tumor microenvironment, leading to suppression of tumor growth in pre-clinical studies
2个月前
已关闭
Targeting the P-selectin/PSGL-1 Pathway: Discovery of Disease-Modifying Therapeutics for Disorders of Thromboinflammation
2个月前
已完结
PSGL-1: A New Player in the Immune Checkpoint Landscape
2个月前
已完结
Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma
2个月前
已完结
The IL-1 family: regulators of immunity
2个月前
已完结
皖公网安备34019202002308
